A& Tax Managing Director Dan Peters was recently featured in Bloomberg Tax's article, 'Trump Pharma Pricing Order Piles on Transfer Pricing'. This article outlines President Donald Trump's executive order related to lowering US medicine prices and explores its implications for transfer pricing and existing tariff policies.
"It’s the latest in a series of things causing pharmaceutical companies to reconsider all aspects of their international tax planning and their transfer pricing, and even further, how they organize their supply chain.”
Mr. Peters provides his perspective on the order, commenting on its anticipated effects on pharmaceutical company's international tax planning and supply chain organization.
Read The Full Article
Budget 2026-27 | Why buyback taxation a victory for minority shareholders and a hurdle for promoters
February 4, 2026
While promoters may find the new tax rates less attractive than the pre-2024 era, the retail and institutional investor community will likely welcome the lower, more transparent capital gains rates.
Indonesia’s PMK No. 112 of 2025: Procedures for Implementing Double Taxation Avoidance Agreements
February 3, 2026
PMK 112 of 2025 sets Indonesia’s DTAA procedures, CoD rules, DGT Form updates, anti‑abuse tests (LOB, PPT), PE guidance, and 10‑day validation timelines.
A&M Tax Policy Quarterly Outlook: Q4 2025
January 30, 2026
Global Tax Policy Q4 2025: Digital economy, SEP vs. Pillar One, TP disputes, OECD MTC remote work PE, Pillar Two SbS safe harbors, and key regional updates.
Thailand’s Renewed BOI Incentives: A Strategic Window for Growth, Expansion, and Investment (2026–2027)
January 29, 2026
On 15 January 2026, the Thailand Board of Investment (BOI) announced a refreshed set of investment promotion measures for companies evaluating expansion opportunities or strategic joint ventures in Thailand.
